Results 91 to 100 of about 16,265,183 (153)

Factors Associated With Discordance Between the Activated Partial Thromboplastin Time and Anti-factor Xa Activity During Extracorporeal Membrane Oxygenation: A Retrospective Cohort Study. [PDF]

Cureus
Simms B, Carmona C, Karam O.
europepmc   +1 more source

Case Report: Differential diagnosis and clinical management of isolated prolonged activated partial thromboplastin time. [PDF]

Front Immunol
Liu L, Guo D.
europepmc   +1 more source

Evaluation of Point-of-Care Coagulation Measurement Systems for Activated Clotting Time and Partial Thromboplastin Time in Heparinized and Non-Heparinized Equine Blood. [PDF]

J Vet Emerg Crit Care (San Antonio)
Hobbs KJ, Ueda Y, Qu Y, Cooper BL, Sheats MK, Burke MJ.   +5 more
europepmc   +1 more source

Is activated partial thromboplastin time prolongation an independent predictor of bleeding in patients with Kyasanur Forest Disease? A retrospective cohort study from southern India. [PDF]

New Microbes New Infect
Gupta N, Sebastian A, Swathikiran PV, Varma M, Mukhopadhyay C, Tirlangi PK.   +5 more
europepmc   +1 more source

New Methods for Activated Partial Thromboplastin Time -Based Clot Waveform Analysis: Normalization and Multi-Parameter Combination. [PDF]

Int J Gen Med
Dong H, Hu Q, Wang H, Li C, Chen H.
europepmc   +1 more source

Effect of Hyperthermia on Prothrombin Time (PT), International Normalized Ratio (INR), and Activated Partial Thromboplastin Time (APTT). [PDF]

Cureus
Devi J, Kakkar N, Sharma A.
europepmc   +1 more source

Association between activated partial thromboplastin time and septic shock in pregnant women: a retrospective cohort study. [PDF]

Front Med (Lausanne)
Zheng S, Chen D, Gao Y.
europepmc   +1 more source

Evaluation of Prothrombin Time and Activated Partial Thromboplastin Time in Antithrombotic-Treated Cardiac Patients: A Cross-Sectional Study from Sana'a City, Yemen. [PDF]

Vasc Health Risk Manag
Amer AH, Al-Adhroey AH, Al-Shammakh AA.
europepmc   +1 more source

Effect of emicizumab-neutralizing antibodies on activated partial thromboplastin time-based clotting time test results in patients treated with emicizumab. [PDF]

Res Pract Thromb Haemost, 2023
Novembrino C, Boscolo-Anzoletti M, Galbiati E, Shinohara S, Peyvandi F.   +4 more
europepmc   +1 more source

Normalization of activated partial thromboplastin time and diluted Russell's viper venom time ratios can be safely omitted in the assessment of lupus anticoagulant. [PDF]

Res Pract Thromb Haemost
Kimiaei A, Antovic J, Gran C.
europepmc   +1 more source